Ascendis Pharma A/S ( ASND ) commenced an underwritten public offering of $300M of American Depositary Shares, each of which represents one ordinary share of Ascendis. In addition, Ascendis expects to grant the underwriters a 30-day option to purchase up to an additional $45M.